Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways
Mirjam C. Boelens(Cancer Research Institute), Andy J. Minn(Cancer Research Institute), Brianne Z. Wiemann(University of Pennsylvania), Tony J. Wu(Cancer Research Institute), Hemant Ishwaran(University of Miami), Barzin Y. Nabet(Gene Therapy Laboratory), Taewon Yoon(Cancer Research Institute), Joyce M. Slingerland(Georgetown University), Jos Jonkers(The Netherlands Cancer Institute), Yu Qiu(Cancer Research Institute), Diana J. Azzam(University of Miami), Petra J. ter Brugge(The Netherlands Cancer Institute), Bihui Xu(Cancer Research Institute), Christina Twyman-Saint Victor(Cancer Research Institute)
Cited by 798
Related Papers
53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers
|Nature Structural & Molecular Biology|2010|1k
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
|Cancer Cell|2021|930